About Us

Improving Outcomes.
Changing Lives.

We recognise that many of the lives of those who need our products have been touched by tragedy and are changed forever.

At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible.

PolyNovo develops innovative medical devices utilising the patented bioabsorbable polymer technology Novosorb®.

NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways.

NovoSorb BTM (Biodegradable Temporising Matrix) is the first product commercialised by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns.

We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.

NovoSorb BTM Milestones


510(K) clearance from the US Food & Drug Administration


Entered Southern Africa market through a distribution agreement


Authorised for supply in Saudi Arabia and Israel


Licensed for supply in India and distributor appointed


Entered on the Australian Register of Therapeutic Goods


Registered for supply in Malaysia


Appointed distributor for Germany, Austria and Switzerland


Registered for supply in Singapore